Ventripoint Issues Shares for Payment of Debenture Interest and Reports on Debenture Conversions

(TheNewswire)

Toronto, Ontario – TheNewswire - February 11,2026 – Ventripoint Diagnostics Ltd.(“Ventripoint” or the “Corporation”, TSXV:VPT) announces it will satisfy debenture interest paymentobligations with the issuance of common shares, subject to TSX VentureExchange (“TSXV”) approval. The Corporation will issue an aggregate of291,344 common shares (“Shares”) for the payment of an aggregate of$36,989.01 of interest owing on certain outstanding ConvertibleDebentures issued by the Corporation on June 28,2024, December 16, 2024, January 17, 2025, and February 7,2025. The Convertible Debentures bear interestat the rate of 10% per annum, payable every 6 months. The Shares willbe issued at a deemed price of $0.127, subject to the approval ofTSXV, and are subject to a hold period of 4 months and one day. Theissuance of the Shares will not create a control person of theCorporation.

The debentures issued January 17, 2025 and February 7,2025, an aggregate of $256,000, have been converted and so no furtherinterest is owing on these series of debentures.

About Ventripoint DiagnosticsLtd.

Ventripoint has become anindustry leader in the application of AI (Artificial Intelligence) toechocardiography. Ventripoint's VMS products are powered by itsproprietary knowledge-based reconstruction technology, which is theresult of a decade of development and provides accurate volumetriccardiac measurements equivalent to MRI. This affordable, gold-standardalternative allows cardiologists greater confidence in the managementof their patients. Providing better care to patients serves as aspringboard and basic standard for all of Ventripoint's productsthat guide our future developments. In addition, VMS+ is versatile andcan be used with all ultrasound systems from any vendor supported byregulatory market approvals in the U.S., Europe and Canada.

For further information, pleasecontact:

Hugh MacNaught

[email protected]

604-671-4201

Neither the TSX Venture Exchange norits Regulation Services Provider (as that term is defined in thepolicies of the TSX Venture Exchange) accepts responsibility for theadequacy or accuracy of this news release.

Forward Looking Statements

This news release contains forward-looking statementsand forward-looking information within the meaning of applicablesecurities laws. The use of any of the words "expect","anticipate", "continue", "estimate","objective", "ongoing", "may","will", "project", "should","believe", "plans", "intends'' andsimilar expressions are intended to identify forward-lookinginformation or statements. The forward-looking statements andinformation are based on certain key expectations and assumptions madeby the Corporation. Although the Corporation believes that theexpectations and assumptions on which such forward-looking statementsand information are based are reasonable, undue reliance should not be placed on the forward-lookingstatements and information because the Corporation can give noassurance that they will prove to be correct.

Since forward-looking statements and informationaddress future events and conditions, by their very nature theyinvolve inherent risks and uncertainties. Actual results could differmaterially from those currently anticipated due to a number of factorsand risks. Factors which could materially affect such forward-lookinginformation are described in the risk factors in theCorporation's most recent annual management's discussion andanalysis that is available on the Corporation's profile on SEDAR+at www.sedarplus.ca. Readers are cautioned that the foregoing list of factors isnot exhaustive. The forward-looking statements included in this newsrelease are expressly qualified by this cautionary statement. Theforward-looking statements and information contained in this newsrelease are made as of the date hereof and the Corporation undertakesno obligation to update publicly or revise any forward-lookingstatements or information, whether as a result of new information,future events or otherwise, unless so required by applicablesecurities laws.

Copyright (c) 2026 TheNewswire - All rights reserved.